Localization, epidemic transitions, and unpredictability of multistrain epidemics with an underlying genotype network.


Journal

PLoS computational biology
ISSN: 1553-7358
Titre abrégé: PLoS Comput Biol
Pays: United States
ID NLM: 101238922

Informations de publication

Date de publication:
02 2021
Historique:
received: 15 08 2020
accepted: 07 12 2020
entrez: 10 2 2021
pubmed: 11 2 2021
medline: 7 7 2021
Statut: epublish

Résumé

Mathematical disease modelling has long operated under the assumption that any one infectious disease is caused by one transmissible pathogen spreading among a population. This paradigm has been useful in simplifying the biological reality of epidemics and has allowed the modelling community to focus on the complexity of other factors such as population structure and interventions. However, there is an increasing amount of evidence that the strain diversity of pathogens, and their interplay with the host immune system, can play a large role in shaping the dynamics of epidemics. Here, we introduce a disease model with an underlying genotype network to account for two important mechanisms. One, the disease can mutate along network pathways as it spreads in a host population. Two, the genotype network allows us to define a genetic distance between strains and therefore to model the transcendence of immunity often observed in real world pathogens. We study the emergence of epidemics in this model, through its epidemic phase transitions, and highlight the role of the genotype network in driving cyclicity of diseases, large scale fluctuations, sequential epidemic transitions, as well as localization around specific strains of the associated pathogen. More generally, our model illustrates the richness of behaviours that are possible even in well-mixed host populations once we consider strain diversity and go beyond the "one disease equals one pathogen" paradigm.

Identifiants

pubmed: 33566810
doi: 10.1371/journal.pcbi.1008606
pii: PCOMPBIOL-D-20-01461
pmc: PMC7875369
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1008606

Subventions

Organisme : NIGMS NIH HHS
ID : P20 GM125498
Pays : United States

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

MMWR Morb Mortal Wkly Rep. 2019 Feb 15;68(6):135-139
pubmed: 30763298
J R Soc Interface. 2009 Jun 6;6(35):509-18
pubmed: 18801714
MMWR Morb Mortal Wkly Rep. 2017 Feb 17;66(6):167-171
pubmed: 28207689
Am J Public Health Nations Health. 1949 Jan;39(1):44-9
pubmed: 18107120
Adv Virus Res. 2003;60:421-67
pubmed: 14689700
J Theor Biol. 2010 Jan 7;262(1):48-57
pubmed: 19766659
Science. 1998 May 8;280(5365):912-5
pubmed: 9572737
Phys Rev E Stat Nonlin Soft Matter Phys. 2002 Mar;65(3 Pt 2A):036104
pubmed: 11909162
Phys Rev E Stat Nonlin Soft Matter Phys. 2012 Sep;86(3 Pt 2):036108
pubmed: 23030981
Theor Popul Biol. 2006 Sep;70(2):164-73
pubmed: 16723145
Phys Rev Lett. 2013 Mar 8;110(10):108103
pubmed: 23521302
Proc Natl Acad Sci U S A. 2017 Aug 22;114(34):8969-8973
pubmed: 28790185
MMWR Morb Mortal Wkly Rep. 2018 Feb 16;67(6):180-185
pubmed: 29447141
Proc Biol Sci. 2002 Feb 7;269(1488):227-33
pubmed: 11839191
Virology. 2017 Mar;503:83-93
pubmed: 28135661
PLoS Pathog. 2010 May 20;6(5):e1000904
pubmed: 20502688
PLoS Comput Biol. 2013;9(2):e1002912
pubmed: 23408880
Sci Rep. 2013;3:2171
pubmed: 23842121
Phys Rev E Stat Nonlin Soft Matter Phys. 2002 Mar;65(3 Pt 1):031915
pubmed: 11909117
Phys Rev Lett. 2003 Dec 12;91(24):247901
pubmed: 14683159
Nature. 2015 Aug 6;524(7563):65-8
pubmed: 26131931
Proc Biol Sci. 2014 Jul 7;281(1786):
pubmed: 24827434
Expert Rev Vaccines. 2010 Nov;9(11):1325-41
pubmed: 21087110
Science. 2017 Nov 17;358(6365):929-932
pubmed: 29097492
Cell. 2016 Oct 20;167(3):684-694.e9
pubmed: 27768891
Nat Commun. 2019 Feb 22;10(1):898
pubmed: 30796206
Theor Popul Biol. 2012 Mar;81(2):102-12
pubmed: 22209755
J Math Biol. 1997 May;35(5):523-44
pubmed: 9145954
J Virol. 2007 Apr;81(8):4315-22
pubmed: 17287258
J Virol. 2010 Oct;84(19):9733-48
pubmed: 20660197
J Math Biol. 2016 Jan;72(1-2):1-24
pubmed: 25800537
MMWR Morb Mortal Wkly Rep. 2015 Jan 16;64(1):10-5
pubmed: 25590680
J R Soc Interface. 2014 Oct 6;11(99):
pubmed: 25100316
PLoS Med. 2007 Jan;4(1):e15
pubmed: 17253900
PLoS One. 2013;8(3):e59529
pubmed: 23555694

Auteurs

Blake J M Williams (BJM)

Vermont Complex Systems Center, University of Vermont, Burlington, Vermont, United States of America.

Guillaume St-Onge (G)

Département de physique, de génie physique et d'optique, Université Laval, Québec, Canada.
Centre interdisciplinaire en modélisation mathématique, Université Laval, Québec, Canada.

Laurent Hébert-Dufresne (L)

Vermont Complex Systems Center, University of Vermont, Burlington, Vermont, United States of America.
Département de physique, de génie physique et d'optique, Université Laval, Québec, Canada.
Department of Computer Science, University of Vermont, Burlington, Vermont, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH